• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米工程纳米药物,赋予其针对肿瘤治疗应用的定制功能。

Nano-engineering nanomedicines with customized functions for tumor treatment applications.

机构信息

Laboratory of Controllable Preparation and Application of Nanomaterials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.

CAS Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.

出版信息

J Nanobiotechnology. 2023 Aug 2;21(1):250. doi: 10.1186/s12951-023-01975-3.

DOI:10.1186/s12951-023-01975-3
PMID:37533106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10399036/
Abstract

Nano-engineering with unique "custom function" capability has shown great potential in solving technical difficulties of nanomaterials in tumor treatment. Through tuning the size and surface properties controllablly, nanoparticles can be endoewd with tailored structure, and then the characteristic functions to improve the therapeutic effect of nanomedicines. Based on nano-engineering, many have been carried out to advance nano-engineering nanomedicine. In this review, the main research related to cancer therapy attached to the development of nanoengineering nanomedicines has been presented as follows. Firstly, therapeutic agents that target to tumor area can exert the therapeutic effect effectively. Secondly, drug resistance of tumor cells can be overcome to enhance the efficacy. Thirdly, remodeling the immunosuppressive microenvironment makes the therapeutic agents work with the autoimmune system to eliminate the primary tumor and then prevent tumor recurrence and metastasis. Finally, the development prospects of nano-engineering nanomedicine are also outlined.

摘要

纳米工程具有独特的“定制功能”能力,在解决肿瘤治疗中纳米材料的技术难题方面显示出巨大的潜力。通过可控地调整尺寸和表面特性,纳米颗粒可以被包封具有定制结构,然后利用这些特征功能来提高纳米药物的治疗效果。基于纳米工程,已经开展了许多工作来推进纳米工程纳米药物的发展。在这篇综述中,主要介绍了与癌症治疗相关的研究,这些研究与纳米工程纳米药物的发展有关。首先,靶向肿瘤区域的治疗剂可以有效地发挥治疗作用。其次,可以克服肿瘤细胞的耐药性,提高疗效。第三,重塑免疫抑制微环境使治疗剂与免疫系统协同作用,以消除原发性肿瘤,然后防止肿瘤复发和转移。最后,还概述了纳米工程纳米药物的发展前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/b90716680aeb/12951_2023_1975_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/1ec37dc263f5/12951_2023_1975_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/4412eddc771c/12951_2023_1975_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/342fffda283a/12951_2023_1975_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/3dfb69adc713/12951_2023_1975_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/60584b8a0989/12951_2023_1975_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/f62e27a52b4a/12951_2023_1975_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/8fe613de7ebb/12951_2023_1975_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/0a21be3fdb1c/12951_2023_1975_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/93bce421858d/12951_2023_1975_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/ce476fc2f751/12951_2023_1975_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/62189ef14645/12951_2023_1975_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/b90716680aeb/12951_2023_1975_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/1ec37dc263f5/12951_2023_1975_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/4412eddc771c/12951_2023_1975_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/342fffda283a/12951_2023_1975_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/3dfb69adc713/12951_2023_1975_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/60584b8a0989/12951_2023_1975_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/f62e27a52b4a/12951_2023_1975_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/8fe613de7ebb/12951_2023_1975_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/0a21be3fdb1c/12951_2023_1975_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/93bce421858d/12951_2023_1975_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/ce476fc2f751/12951_2023_1975_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/62189ef14645/12951_2023_1975_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c93/10399036/b90716680aeb/12951_2023_1975_Fig11_HTML.jpg

相似文献

1
Nano-engineering nanomedicines with customized functions for tumor treatment applications.纳米工程纳米药物,赋予其针对肿瘤治疗应用的定制功能。
J Nanobiotechnology. 2023 Aug 2;21(1):250. doi: 10.1186/s12951-023-01975-3.
2
Combining Nanomedicine and Immunotherapy.纳米医学与免疫疗法的联合应用。
Acc Chem Res. 2019 Jun 18;52(6):1543-1554. doi: 10.1021/acs.accounts.9b00148. Epub 2019 May 23.
3
Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices.表面工程多功能纳米系统用于甲状腺癌的局部药物递送:当前实践综述。
Biomed Pharmacother. 2024 Jul;176:116840. doi: 10.1016/j.biopha.2024.116840. Epub 2024 May 30.
4
Promising Nanomedicines of Shikonin for Cancer Therapy.紫草素在癌症治疗中的有前景的纳米药物。
Int J Nanomedicine. 2023 Mar 10;18:1195-1218. doi: 10.2147/IJN.S401570. eCollection 2023.
5
Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.影响癌症纳米药物递送效率的因素。
AAPS PharmSciTech. 2020 May 14;21(4):132. doi: 10.1208/s12249-020-01691-3.
6
Tumor Abnormality-Oriented Nanomedicine Design.肿瘤导向的纳米医学设计。
Chem Rev. 2023 Sep 27;123(18):10920-10989. doi: 10.1021/acs.chemrev.3c00062. Epub 2023 Sep 15.
7
Multi-functionalization, a Promising Adaptation to Overcome Challenges to Clinical Translation of Nanomedicines as Nano-diagnostics and Nano-therapeutics for Breast Cancer.多功能化:克服纳米药物向癌症诊断和治疗临床转化挑战的一种有前景的策略
Curr Pharm Des. 2021;27(43):4356-4375. doi: 10.2174/1381612827666210830092539.
8
Cell surface-nanoengineering for cancer targeting immunoregulation and precise immunotherapy.细胞表面纳米工程用于癌症靶向免疫调节和精确免疫治疗。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jul-Aug;15(4):e1875. doi: 10.1002/wnan.1875. Epub 2022 Dec 26.
9
Tumor-Targeted Nanomedicine for Immunotherapy.肿瘤靶向纳米医学免疫治疗。
Acc Chem Res. 2020 Dec 15;53(12):2765-2776. doi: 10.1021/acs.accounts.0c00518. Epub 2020 Nov 8.
10
Remodeling tumor microenvironment with nanomedicines.用纳米药物重塑肿瘤微环境。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Nov;13(6):e1730. doi: 10.1002/wnan.1730. Epub 2021 Jun 14.

引用本文的文献

1
ROS-Responsive Nanoprobes for Bimodal Imaging-Guided Cancer Targeted Combinatorial Therapy.用于双模态成像引导的癌症靶向联合治疗的 ROS 响应型纳米探针。
Int J Nanomedicine. 2024 Aug 7;19:8071-8090. doi: 10.2147/IJN.S467512. eCollection 2024.
2
Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer.载有小干扰 RNA YTHDF1 的光敏双靶向铬纳米颗粒用于肝癌的分子靶向免疫治疗。
J Nanobiotechnology. 2024 Jun 19;22(1):348. doi: 10.1186/s12951-024-02612-3.
3
Potential of Nano-Engineered Stem Cells in the Treatment of Multiple Sclerosis: A Comprehensive Review.

本文引用的文献

1
N-Heterocyclic Carbene Boranes: Dual Reagents for the Synthesis of Gold Nanoparticles.N-杂环卡宾硼烷:用于合成金纳米粒子的双功能试剂
Chemistry. 2023 Aug 15;29(46):e202301610. doi: 10.1002/chem.202301610. Epub 2023 Jul 14.
2
Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?在癌症治疗中靶向 EGFR 信号通路:2023 年有哪些新进展?
Expert Opin Ther Targets. 2023 Apr-May;27(4-5):305-324. doi: 10.1080/14728222.2023.2218613. Epub 2023 Jun 2.
3
Detailed curriculum vitae of HER2-targeted therapy.HER2 靶向治疗的详细简历。
纳米工程化干细胞在多发性硬化症治疗中的潜力:全面综述。
Cell Mol Neurobiol. 2023 Dec 17;44(1):6. doi: 10.1007/s10571-023-01434-5.
Pharmacol Ther. 2023 May;245:108417. doi: 10.1016/j.pharmthera.2023.108417. Epub 2023 Apr 17.
4
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies.髓源性抑制细胞:血液系统恶性肿瘤中的关键免疫抑制调节因子及治疗靶点
Biomark Res. 2023 Mar 29;11(1):34. doi: 10.1186/s40364-023-00475-8.
5
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.主动靶向纳米药物递送系统在骨肉瘤治疗中的应用。
J Nanobiotechnology. 2023 Mar 22;21(1):103. doi: 10.1186/s12951-023-01826-1.
6
Mechanisms of drug resistance in breast cancer liver metastases: Dilemmas and opportunities.乳腺癌肝转移中的耐药机制:困境与机遇
Mol Ther Oncolytics. 2023 Feb 6;28:212-229. doi: 10.1016/j.omto.2023.02.001. eCollection 2023 Mar 16.
7
Research progress of yolk-shell structured nanoparticles and their application in catalysis.蛋黄壳结构纳米粒子的研究进展及其在催化中的应用
RSC Adv. 2023 Jan 12;13(3):2140-2154. doi: 10.1039/d2ra07541e. eCollection 2023 Jan 6.
8
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.靶向纳米药物重塑免疫抑制性肿瘤微环境以增强癌症免疫治疗。
Acta Pharm Sin B. 2022 Dec;12(12):4327-4347. doi: 10.1016/j.apsb.2022.11.001. Epub 2022 Nov 4.
9
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment.基于纳米技术的方法通过诊断和治疗克服肺癌耐药性。
Drug Resist Updat. 2023 Jan;66:100904. doi: 10.1016/j.drup.2022.100904. Epub 2022 Nov 28.
10
Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides.通过整合素结合肽将治疗性纳米颗粒递送至各种癌症。
Int J Mol Sci. 2022 Nov 8;23(22):13735. doi: 10.3390/ijms232213735.